The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Acute Lung Injury-Global Market Insights and Sales Trends 2024

Acute Lung Injury-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1858711

No of Pages : 101

Ask Your Query

Synopsis

The global Acute Lung Injury market size is expected to reach US$ 722.9 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Acute Lung Injury in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Acute Lung Injury market. Pharmacotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mechanical Ventilation segment is estimated at % CAGR for the next seven-year period.

Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Acute Lung Injury, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Acute Lung Injury market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Acute Lung Injury market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Acute Lung Injury sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Acute Lung Injury covered in this report include Altor BioScience, FirstString Research, GlaxoSmithKline, Forschung und Entwicklung, Commence Bio, CompleGen, Histocell S.L., Stemedica Cell Technologies and Windtree Therapeutics, etc.

The global Acute Lung Injury market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Altor BioScience
  • FirstString Research
  • GlaxoSmithKline
  • Forschung und Entwicklung
  • Commence Bio
  • CompleGen
  • Histocell S.L.
  • Stemedica Cell Technologies
  • Windtree Therapeutics
  • S-Evans Biosciences

Global Acute Lung Injury market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Acute Lung Injury market, Segment by Type:

  • Pharmacotherapy
  • Mechanical Ventilation
  • Adjunctive Procedures
  • Fluid Management
  • Others

Global Acute Lung Injury market, by Application

  • Hospitals
  • Clinics
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Acute Lung Injury companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Acute Lung Injury
1.1 Acute Lung Injury Market Overview
1.1.1 Acute Lung Injury Product Scope
1.1.2 Acute Lung Injury Market Status and Outlook
1.2 Global Acute Lung Injury Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acute Lung Injury Market Size by Region (2018-2029)
1.4 Global Acute Lung Injury Historic Market Size by Region (2018-2023)
1.5 Global Acute Lung Injury Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acute Lung Injury Market Size (2018-2029)
1.6.1 North America Acute Lung Injury Market Size (2018-2029)
1.6.2 Europe Acute Lung Injury Market Size (2018-2029)
1.6.3 Asia-Pacific Acute Lung Injury Market Size (2018-2029)
1.6.4 Latin America Acute Lung Injury Market Size (2018-2029)
1.6.5 Middle East & Africa Acute Lung Injury Market Size (2018-2029)
2 Acute Lung Injury Market by Type
2.1 Introduction
2.1.1 Pharmacotherapy
2.1.2 Mechanical Ventilation
2.1.3 Adjunctive Procedures
2.1.4 Fluid Management
2.1.5 Others
2.2 Global Acute Lung Injury Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acute Lung Injury Historic Market Size by Type (2018-2023)
2.2.2 Global Acute Lung Injury Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acute Lung Injury Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acute Lung Injury Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acute Lung Injury Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acute Lung Injury Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acute Lung Injury Revenue Breakdown by Type (2018-2029)
3 Acute Lung Injury Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Acute Lung Injury Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acute Lung Injury Historic Market Size by Application (2018-2023)
3.2.2 Global Acute Lung Injury Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acute Lung Injury Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acute Lung Injury Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acute Lung Injury Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acute Lung Injury Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acute Lung Injury Revenue Breakdown by Application (2018-2029)
4 Acute Lung Injury Competition Analysis by Players
4.1 Global Acute Lung Injury Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Lung Injury as of 2022)
4.3 Date of Key Players Enter into Acute Lung Injury Market
4.4 Global Top Players Acute Lung Injury Headquarters and Area Served
4.5 Key Players Acute Lung Injury Product Solution and Service
4.6 Competitive Status
4.6.1 Acute Lung Injury Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Altor BioScience
5.1.1 Altor BioScience Profile
5.1.2 Altor BioScience Main Business
5.1.3 Altor BioScience Acute Lung Injury Products, Services and Solutions
5.1.4 Altor BioScience Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.1.5 Altor BioScience Recent Developments
5.2 FirstString Research
5.2.1 FirstString Research Profile
5.2.2 FirstString Research Main Business
5.2.3 FirstString Research Acute Lung Injury Products, Services and Solutions
5.2.4 FirstString Research Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.2.5 FirstString Research Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Acute Lung Injury Products, Services and Solutions
5.3.4 GlaxoSmithKline Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.3.5 Forschung und Entwicklung Recent Developments
5.4 Forschung und Entwicklung
5.4.1 Forschung und Entwicklung Profile
5.4.2 Forschung und Entwicklung Main Business
5.4.3 Forschung und Entwicklung Acute Lung Injury Products, Services and Solutions
5.4.4 Forschung und Entwicklung Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.4.5 Forschung und Entwicklung Recent Developments
5.5 Commence Bio
5.5.1 Commence Bio Profile
5.5.2 Commence Bio Main Business
5.5.3 Commence Bio Acute Lung Injury Products, Services and Solutions
5.5.4 Commence Bio Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.5.5 Commence Bio Recent Developments
5.6 CompleGen
5.6.1 CompleGen Profile
5.6.2 CompleGen Main Business
5.6.3 CompleGen Acute Lung Injury Products, Services and Solutions
5.6.4 CompleGen Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.6.5 CompleGen Recent Developments
5.7 Histocell S.L.
5.7.1 Histocell S.L. Profile
5.7.2 Histocell S.L. Main Business
5.7.3 Histocell S.L. Acute Lung Injury Products, Services and Solutions
5.7.4 Histocell S.L. Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.7.5 Histocell S.L. Recent Developments
5.8 Stemedica Cell Technologies
5.8.1 Stemedica Cell Technologies Profile
5.8.2 Stemedica Cell Technologies Main Business
5.8.3 Stemedica Cell Technologies Acute Lung Injury Products, Services and Solutions
5.8.4 Stemedica Cell Technologies Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.8.5 Stemedica Cell Technologies Recent Developments
5.9 Windtree Therapeutics
5.9.1 Windtree Therapeutics Profile
5.9.2 Windtree Therapeutics Main Business
5.9.3 Windtree Therapeutics Acute Lung Injury Products, Services and Solutions
5.9.4 Windtree Therapeutics Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.9.5 Windtree Therapeutics Recent Developments
5.10 S-Evans Biosciences
5.10.1 S-Evans Biosciences Profile
5.10.2 S-Evans Biosciences Main Business
5.10.3 S-Evans Biosciences Acute Lung Injury Products, Services and Solutions
5.10.4 S-Evans Biosciences Acute Lung Injury Revenue (US$ Million) & (2018-2023)
5.10.5 S-Evans Biosciences Recent Developments
6 North America
6.1 North America Acute Lung Injury Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Acute Lung Injury Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acute Lung Injury Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acute Lung Injury Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acute Lung Injury Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acute Lung Injury Market Dynamics
11.1 Acute Lung Injury Industry Trends
11.2 Acute Lung Injury Market Drivers
11.3 Acute Lung Injury Market Challenges
11.4 Acute Lung Injury Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock